This section provides the financial market, owners and other interested parties with correct, relevant and timely information about our business and our performance. Investor information is released in Swedish for regulatory reasons and translated into English on a report-to-report basis. Please contact Redsense for additional information.
Press Releases
Regulatory
Non-regulatory
Redsense Medical to present at the Life Science Investor Forum
Regulatory
Interim Report Q3 – January – September, 2023 Redsense Medical AB (publ)
Regulatory
Nomination Committee appointed for the 2024 Annual General Meeting of Redsense Medical AB
Non-regulatory
Redsense Medical to present at the Small Cap Growth Virtual Investor Conference
Non-regulatory